COHERUS ONCOLOGY INC
CHRS·19249H103·US·Common Stock·Healthcare - Biotechnology-13D/G
CHRS (COHERUS ONCOLOGY INC) is held by 94 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($17.5M), VANGUARD CAPITAL MANAGEMENT LLC ($9.2M), GEODE CAPITAL MANAGEMENT, LLC ($5.3M). Net institutional sentiment: Mixed.
94
Holders
Avg rating(25 Elite)
$72M
Total Value
64% (99)
Fund Consensus
56 buying - 31 selling
Who's Trading
ActivistTGTimothy G. Youngquist 2020 Irrevocable Trust8.3%May 15, 2026
ActivistTAThomas A. Satterfield, Jr.4.6%Apr 29, 2026
ActivistBIBering Partners II, L.P. ("Bering II")4.1%Nov 4, 2025
InsiderWMWahlstrom MatsSell $74KMay 23, 2025
13F: Insider & Congress:
Showing 1-20 of 99
1 / 5
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer